866-997-4948(US-Canada Toll Free)

China Intravenous (IV) Iron Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 99 Pages

Notes:
Sales, means the sales volume of Intravenous (IV) Iron Drugs
Revenue, means the sales value of Intravenous (IV) Iron Drugs

This report studies Intravenous (IV) Iron Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
AMAG Pharmaceuticals
Actavis
Galenica
Vifor Pharma
Luitpold Pharmaceuticals
Pharmacosmos A/S
American Regent
Fresenius Medical Care AG & Co. KGaA
Anofi US
Takeda Pharmaceutical

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by Application, this report focuses on consumption, market share and growth rate of Intravenous (IV) Iron Drugs in each application, can be divided into
Application 1
Application 2

Table of Contents

China Intravenous (IV) Iron Drugs Market Research Report 2017
1 Intravenous (IV) Iron Drugs Market Overview
1.1 Product Overview and Scope of Intravenous (IV) Iron Drugs
1.2 Intravenous (IV) Iron Drugs Segment by Type
1.2.1 China Production Market Share of Intravenous (IV) Iron Drugs Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Applications of Intravenous (IV) Iron Drugs
1.3.1 Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.4 China Market Size (Value) of Intravenous (IV) Iron Drugs (2012-2022)
1.5 China Intravenous (IV) Iron Drugs Status and Outlook
1.6 Government Policies

2 China Intravenous (IV) Iron Drugs Market Competition by Manufacturers
2.1 China Intravenous (IV) Iron Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Intravenous (IV) Iron Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Intravenous (IV) Iron Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intravenous (IV) Iron Drugs Market Competitive Situation and Trends
2.5.1 Intravenous (IV) Iron Drugs Market Concentration Rate
2.5.2 Intravenous (IV) Iron Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Intravenous (IV) Iron Drugs Manufacturers Profiles/Analysis
3.1 AMAG Pharmaceuticals
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Actavis
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Actavis Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Galenica
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Galenica Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Vifor Pharma
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Vifor Pharma Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Luitpold Pharmaceuticals
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Pharmacosmos A/S
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Pharmacosmos A/S Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 American Regent
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 American Regent Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Fresenius Medical Care AG & Co. KGaA
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Anofi US
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Anofi US Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Takeda Pharmaceutical
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview

4 China Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Intravenous (IV) Iron Drugs Capacity, Production and Growth (2012-2017)
4.2 China Intravenous (IV) Iron Drugs Revenue and Growth (2012-2017)
4.3 China Intravenous (IV) Iron Drugs Production, Consumption, Export and Import (2012-2017)

5 China Intravenous (IV) Iron Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Intravenous (IV) Iron Drugs Production and Market Share by Type (2012-2017)
5.2 China Intravenous (IV) Iron Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Intravenous (IV) Iron Drugs Price by Type (2012-2017)
5.4 China Intravenous (IV) Iron Drugs Production Growth by Type (2012-2017)

6 China Intravenous (IV) Iron Drugs Market Analysis by Application
6.1 China Intravenous (IV) Iron Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaIntravenous (IV) Iron Drugs Market Analysis by Regions (Provinces)
7.1 China Intravenous (IV) Iron Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Intravenous (IV) Iron Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Intravenous (IV) Iron Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Intravenous (IV) Iron Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Intravenous (IV) Iron Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Intravenous (IV) Iron Drugs Production, Consumption, Export and Import (2012-2017)

8 Intravenous (IV) Iron Drugs Manufacturing Cost Analysis
8.1 Intravenous (IV) Iron Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Intravenous (IV) Iron Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Intravenous (IV) Iron Drugs Market Forecast (2017-2022)
12.1 China Intravenous (IV) Iron Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Intravenous (IV) Iron Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Intravenous (IV) Iron Drugs Production Forecast by Type (2017-2022)
12.4 China Intravenous (IV) Iron Drugs Consumption Forecast by Application (2017-2022)
12.5 China Intravenous (IV) Iron Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Intravenous (IV) Iron Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Intravenous (IV) Iron Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Intravenous (IV) Iron Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Intravenous (IV) Iron Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Intravenous (IV) Iron Drugs
Figure China Production Market Share of Intravenous (IV) Iron Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure China Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Intravenous (IV) Iron Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Intravenous (IV) Iron Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Intravenous (IV) Iron Drugs Capacity of Key Manufacturers in 2015
Figure China Intravenous (IV) Iron Drugs Capacity of Key Manufacturers in 2016
Table China Intravenous (IV) Iron Drugs Production of Key Manufacturers (2015 and 2016)
Table China Intravenous (IV) Iron Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Intravenous (IV) Iron Drugs Production Share by Manufacturers
Figure 2016 Intravenous (IV) Iron Drugs Production Share by Manufacturers
Table China Intravenous (IV) Iron Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Intravenous (IV) Iron Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Intravenous (IV) Iron Drugs Revenue Share by Manufacturers
Table 2016 China Intravenous (IV) Iron Drugs Revenue Share by Manufacturers
Table China Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Intravenous (IV) Iron Drugs Product Type
Figure Intravenous (IV) Iron Drugs Market Share of Top 3 Manufacturers
Figure Intravenous (IV) Iron Drugs Market Share of Top 5 Manufacturers
Table AMAG Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Actavis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actavis Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Actavis Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Galenica Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galenica Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Galenica Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Vifor Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vifor Pharma Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Vifor Pharma Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Luitpold Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Pharmacosmos A/S Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pharmacosmos A/S Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pharmacosmos A/S Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table American Regent Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table American Regent Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure American Regent Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Fresenius Medical Care AG & Co. KGaA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Anofi US Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Anofi US Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Anofi US Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Intravenous (IV) Iron Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Intravenous (IV) Iron Drugs Market Share (2012-2017)
Figure China Intravenous (IV) Iron Drugs Capacity, Production and Growth (2012-2017)
Figure China Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Intravenous (IV) Iron Drugs Production, Consumption, Export and Import (2012-2017)
Table China Intravenous (IV) Iron Drugs Production by Type (2012-2017)
Table China Intravenous (IV) Iron Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Intravenous (IV) Iron Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Intravenous (IV) Iron Drugs by Type
Table China Intravenous (IV) Iron Drugs Revenue by Type (2012-2017)
Table China Intravenous (IV) Iron Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Intravenous (IV) Iron Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Intravenous (IV) Iron Drugs by Type
Table China Intravenous (IV) Iron Drugs Price by Type (2012-2017)
Figure China Intravenous (IV) Iron Drugs Production Growth by Type (2012-2017)
Table China Intravenous (IV) Iron Drugs Consumption by Application (2012-2017)
Table China Intravenous (IV) Iron Drugs Consumption Market Share by Application (2012-2017)
Figure China Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015
Table China Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017)
Table China Intravenous (IV) Iron Drugs Production by Regions (Provinces)(2012-2017)
Table China Intravenous (IV) Iron Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Intravenous (IV) Iron Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Intravenous (IV) Iron Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Intravenous (IV) Iron Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Intravenous (IV) Iron Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Intravenous (IV) Iron Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Intravenous (IV) Iron Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous (IV) Iron Drugs
Figure Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
Figure Intravenous (IV) Iron Drugs Industrial Chain Analysis
Table Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015
Table Major Buyers of Intravenous (IV) Iron Drugs
Table Distributors/Traders List
Figure China Intravenous (IV) Iron Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Intravenous (IV) Iron Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Intravenous (IV) Iron Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Intravenous (IV) Iron Drugs Production Forecast by Type (2017-2022)
Table China Intravenous (IV) Iron Drugs Consumption Forecast by Application (2017-2022)
Table China Intravenous (IV) Iron Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Intravenous (IV) Iron Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Intravenous (IV) Iron Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *